Clearasil Rapid Rescue Deep Treatment Pads Cloth
FDA Recall NDC 63824-431
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Clearasil Rapid Rescue Deep Treatment Pads (NDC 63824-431). A significant event, classified as Class III, was initiated on Aug 29, 2023 by Reckitt Benckiser Llc. The reported reason for this action was: "Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging."
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
Class III Terminated
Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.
Aug 29, 2023
Oct 04, 2023
6,072 cases/36,426 individual selling units
Recall Profile & Regulatory Data
Event ID
92977
Classification
Class III
Enforcement Status
Terminated
Recalling Firm
RB Health (US) LLC
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
USA nationwide
Termination Date
Apr 22, 2025
Product Description
Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90
Batch or Lot Expiration Information
Lot# KT220211, Exp 07/2024
Affected Packages Involved in this Recall
63824-431-90Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
